GLP-1: glucagon-like peptide 1; GIP: gastric inhibitory peptide; PERT: pancreatic enzyme replacement therapy; TCF7L2: transcription factor 7-like 2; CFRD: cystic fibrosis-related diabetes. This evidence concerns the gene TCF7L2 and cystic fibrosis-related diabetes.